EXTENsivim experiments on careinogenesis in bone by bone seeking isotopes have been made by Finkel and her co-workers (Finkel, 1959) and an analysis (Mole, 1962) (1959).
The strontium-90 was given in a single injection in doses similar to those used by Finkel (1959) but intraperitoneally, not intravenously. One pure line C57BL/Rij and one hybrid CBA/Rij x C57BL/Rij were used, both strains being different from the CF No. 1 used by Finkel (1959) .
In experiments in which mice are allowed to die or are kifed when they have a large bone tumour, the time intervalr between the administration of the strontium-90 and death will be the sum of the time required for tumour induction and the time required for the tumour to develop to the point at which it kins. If the tumour development time is 0, then r 0 will be the tumour induction time. It is supposed that the number of radioactive events occurring in the skeleton in r 0 determines the probabihty of induction of a killing bone tumour. With strontium isotopes the whole body burden may be taken as equivalent to the amount in the skeleton and the number of radioactive events in r 0 can be calculated if the amount of strontium-90 in the body at any time after administration is known. Fortunately it is an empirical fact that the retention of strontium-90 can be described by a power function and that the data necessary for determining the parameters are available for the Dutch as well as for the American mice.
The age-specific tumour death rate, the probability of dying with a bone tumour during the interval t to t + 50 days, Wloft, can be derived by dividing the number of mice dying ' Vries, 1962 ; van Putten, 1962) give points which cluster about each other. The data of Finkel (1959) on tumour production after single doses of stroii-tium-90 refer to five different doses over a 10-fold range and give just as good a fit with expectation (Mole, 1962 (1959) , perhaps encouraging the conclusion that there is some real meaning in the bypothesis employed in the analysis of the data. Effect of a low pho8phoru,3 diet van Putten (1962) also determined the bone tumour incidence in two further groups of mice B and C which were maintained on a diet very low in phosphorus (less than 0-02 per cent P) for a period of six weeks after administration of the strontium-90. The rate of elimination of strontium-9.0 was markedly increased by this regimen. Group C was put on the low phosphorus diet during the period [13] [14] [15] [16] [17] [18] [19] (van Putten, 1962 ;  and Fig. 1 ).
Group B mice were put on the low phosphorus diet much earlier than Group C, from days 2-44. The result was that from 13 weeks on the body burden of Group B was about half that of Group A mice and the number of radioactive events occurring in the skeleton of mice of Group B in any time interval was correspondingly less. In qualitative conformity with the hypothesis the median life span was longer, 392 days, and the overall incidence of bone tumours reduced (van Putten, 1962 At the level of administered dose used by Finkel (1959) Species differences in 0 must be expected*-data on radium and plutonium iiiduced tumours suggest that 0 may be 6-10 times longer in the beagle than in the mouse-and it is well known that different individual tumours within the same animal or in different members of the same species grow at different rates, at least from the moment at which they can be first recognised as definite tumours. This has been clearly demonstrated for strontium-induced bone tumours in the mouse (Finkel, Bergstrand and Biskis, 1961) . The justification for using a fixed 0 = 150 days in considering mouse experiments is merely that this simplifies the analysis and yet allows the expected pattern to emerge. * The time of first appearance of bone tumours in CBA and CF No. I mice given the same dose of 9OSr was different (Finkel, Bergstrand and Biskis, 1961) . This could be due to a difference in retention or a difference in 0 between the two strains of mice.
If there is a spread of tumour development times around a mean 0, then the observed 0 for the earliest appearing tumours will indicate the lower part of the range of 0. In experiments on careinogenesis in bone, cumulative tumour incidence cannot be determined since there is a progressive loss from the experiment of each animal with a large tumour. However, it is possible to determine dTIdt, the total number of tumo-urs found in all the animals dying in a given period divided by the number of animals alive at the beginning of the period and, if death is due regularly to a particularly large bone tumour, it may not be too far from the truth to consider that the tumours discoverable by a standard set of criteria in any one (Fig. 2) . Thus it appears possible that a two-event hypothesis may fit the combined data for all the tumours as well as the limited data where each animal is counted only once however many tumou-rs it may have (Fig. 1) . The fact that the slope of the straight line in Fig. 2 is six times that of the slope in Fig. I 
